IRhythm Technologies, Inc.
IRTC
Classement en actions
#4248
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to... iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Prix de l'action
$113.26
Capitalisation boursière
$3.73B
Changement (1 jour)
-0.52%
Changement (1 an)
-36.43%
Pays
US
Échange IRhythm Technologies, Inc. (IRTC)
Catégorie
Healthcare
Revenus pour IRhythm Technologies, Inc. (IRTC)
Revenus en Jun 2026 TTM : $825.34M
Selon les derniers rapports financiers de IRhythm Technologies, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $825.34M. En 2023, l'entreprise a réalisé un chiffre d'affaires de $492.68M une augmentation par rapport à le chiffre d'affaires de l'année 2022, qui était de $410.92M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour IRhythm Technologies, Inc. de 2013 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $825.34M | 39.45% |
| 2024 | $591.84M | 20.13% |
| 2023 | $492.68M | 19.90% |
| 2022 | $410.92M | 27.29% |
| 2021 | $322.83M | 21.74% |
| 2020 | $265.17M | 23.59% |
| 2019 | $214.55M | 45.68% |
| 2018 | $147.28M | 48.57% |
| 2017 | $99.13M | 54.72% |
| 2016 | $64.07M | 77.29% |
| 2015 | $36.14M | 66.17% |
| 2014 | $21.75M | 41.52% |
| 2013 | $15.37M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $46.59B | 5,544.37% |
US
|
|
| $35.48B | 4,199.34% |
IE
|
|
| $25.84B | 3,030.48% |
US
|
|
| $21.00B | 2,443.93% |
US
|
|
| - | - |
DE
|
